The primary endpoint of LEADERS FREE III was presented at PCR e-course 2020
June 27,2020 | News | BioFreedom™ Ultra
The study evaluates the safety and efficacy of the novel thin-strut (84µm) CoCr polymer-free DCS BioFreedom™ Ultra in HBR patients. Details are available in Professor Eberli’s presentation.
NEWEST INNOVATION COMING SOON...
BIOFREEDOM™ ULTRA, A COBALT CHROMIUM POLYMER AND CARRIER-FREE DRUG COATED CORONARY STENT SYSTEM (DCS)
June 12, 2020 | News | BioFreedom™ Ultra
Pending CE marking of this new product in Biosensors interventional cardiology portfolio, the results of the LEADERS FREE III study will be presented at the PCR eCOURSE 2020
Blue Sail / Biosensors Intl. enters the Structural Heart business and welcomes NVT into the group
June 9,2020 | News | Corporate information
Biosensors International, part of Blue Sail Medical, announced today the completion of its acquisition of
NVT AG, Muri (Argau, Switzerland), which was previously communicated on September 20, 2019.
NEW ARC HBR DEFINITION
June 20,2019 | News | BioFreedom
For 7 years, we have been providing solutions to study and treat HBR patients.
Biosensors is proud to have contributed to increase the awareness of HBR patients who require an
Now, a new ARC HBR definition will continue to improve the care of these patients.
NEW: RISE™ NC NON-COMPLIANT BALLOON
July 8, 2019 | News | Rise
RISE™ NC provides you a new device to complement your tools during your procedure, delivering on the
performance you need. RISE NC is designed for deliverability and durability to allow for confident treatment
of your patients.
NEW CHIEF MEDICAL OFFICER OF BIOSENSORS INTERNATIONAL
June 2, 2020 | News | Corporate information
Prof. Oldroyd was a Consultant Interventional Cardiologist in the Golden Jubilee National Hospital, Glasgow,
UK and has a career experience of more than 9000 PCI procedures. He also has significant experience of both
TAVI and Mitraclip procedures.